Search Results for 'T2dm-Patients'

T2dm-Patients published presentations and documents on DocSlides.

Cyto T2DM 3 Cyto ND 2 Cyto

Cyto T2DM 3 Cyto ND 2 Cyto

by layla

T2DM 1. Cyto. T2DM 5. Cyto. ND 4. Cyto. ND 5. C...

Page 2 of 19al Cardiovasc Diabetol 2018 1783

Page 2 of 19al Cardiovasc Diabetol 2018 1783

by alis

Backgrounde International Diabetes Federation (ID...

Diabetic Ketoacidosis in Type 2 Diabetics

Diabetic Ketoacidosis in Type 2 Diabetics

by RefreshingView

Tom Heaps. Consultant Acute Physician. Case 1. 82-...

Making the Case for Metabolic Surgery in Patients With

Making the Case for Metabolic Surgery in Patients With

by tatyana-admore

Obesity and T2DM. Introduction/Overview . Obesity...

Prediabetes Management AACE

Prediabetes Management AACE

by danika-pritchard

Prediabetes. Consensus Statement: Summary. Untre...

Nonalcoholic Fatty Liver

Nonalcoholic Fatty Liver

by luanne-stotts

Disease. . s_khalilzadeh. A Nove...

Expert Forum Diabetes and Mental Health

Expert Forum Diabetes and Mental Health

by walsh

David J. Robinson • Michael J. Coons • Jean-Fr...

Jarolim et al. Diab Care 2018

Jarolim et al. Diab Care 2018

by anastasia

NT-. proBNP. . concentrations identify . T2DM . p...

Type 2 Diabetes in Asian Americans

Type 2 Diabetes in Asian Americans

by ashley

by Sun H. Kim, MD MS. Associate Professor of Medic...

Oral Hypoglycemic agent

Oral Hypoglycemic agent

by jainy

Treatment of T2DM. A.Amouzegar. , MD. Endocrine Re...

Prediabetes Burden Epidemiology:

Prediabetes Burden Epidemiology:

by calandra-battersby

Health Performance Gaps . Prevalence. Risk factor...

SGLT-2 Inhibitor with Incretins

SGLT-2 Inhibitor with Incretins

by pamella-moone

Add on to insulin. EFFICACY AND TOLERABILITY. OF ...

Reducing the Risk of Developing Diabetes

Reducing the Risk of Developing Diabetes

by lindy-dunigan

Chapter 5. Thomas . Ransom, Ronald Goldenberg, Am...

Application of a new method of noninvasive

Application of a new method of noninvasive

by alistair

assessment of carbohydrate metabolism disorders in...

Redefining Quality Care in T2DM Patients with CV Disease

Redefining Quality Care in T2DM Patients with CV Disease

by eddey

Melissa L. Magwire RN CDE. Heart House Round Table...

IN THE NAME OF ALLAH Diabetic Nephropathy

IN THE NAME OF ALLAH Diabetic Nephropathy

by victoria

. Shahin. . Nosratzehi. . volume . 14 | JUNE 20...

MunichPersonalRePEcArchive

MunichPersonalRePEcArchive

by amey

Prevalenceofneuro-musculoskeletalcomplicationsinpa...

IOSR Journal of Dental and Medical Sciences IOSR

IOSR Journal of Dental and Medical Sciences IOSR

by susan2

- JDMS) e - ISSN : 2279 - 0853, p - ISSN: 2279 - ...

Food Sci Technol Campinas 412 349354 AprJune 2021

Food Sci Technol Campinas 412 349354 AprJune 2021

by emery

349/354 349Food Science and TechnologyOI Dhttps/...

Faculty Caroline M. Apovian

Faculty Caroline M. Apovian

by heavin

, MD, FACP, FTOS, DABOM. Co-Director, Center for W...

Machine Learning to Predict the Ischemic Stroke among

Machine Learning to Predict the Ischemic Stroke among

by tremblay

Type 2 Diabetes Mellitus Patients using Taipei Med...

Kaur KK Allahbadia G Singh M Importance of simultaneous treatment o

Kaur KK Allahbadia G Singh M Importance of simultaneous treatment o

by ani

Copyright 2019 by Kaur KK. This is an open-access ...

Current Therapy in Type 2 Diabetes:

Current Therapy in Type 2 Diabetes:

by Dragonlord

What Follows Metformin? . James R. Gavin III, MD, ...

Long -Term Efficacy of Dapagliflozin in T2DM Patients Receiving

Long -Term Efficacy of Dapagliflozin in T2DM Patients Receiving

by vamput

High-Dose Insulin. John . P.H. . Wilding, DM, FRCP...

Diagnosing Nonalcoholic

Diagnosing Nonalcoholic

by faustina-dinatale

Fatty Liver Disease. Anna Christina Dela Cruz, MD...

Patient Outcomes in Bariatric Surgery: Bridging the Divide to Postoperative Success

Patient Outcomes in Bariatric Surgery: Bridging the Divide to Postoperative Success

by calandra-battersby

Introduction/Background. Bariatric (Metabolic) Su...

Session III: Application and Authoring

Session III: Application and Authoring

by tawny-fly

Luke Rasmussen. Feinberg School of Medicine, Nort...

by min-jolicoeur

Patel University. Efficacy of Urinary N-Ace...

Risk factors for metformin-induced vitamin B12 deficiency a

Risk factors for metformin-induced vitamin B12 deficiency a

by natalia-silvester

T2DM patients. Marwan Ahmed. Dr. George . Muntin...

. Type 2 diabetes and the

. Type 2 diabetes and the

by rodriguez

DiRECT. . Trial. Mike Lean. Glasgow Royal . Infrm...

The Evolution of Cardiovascular Outcomes Trials in T2DM Over the Years

The Evolution of Cardiovascular Outcomes Trials in T2DM Over the Years

by harmony

Darren K. McGuire, MD, . MHSc. Professor of Medici...

CURRENT MANAGEMENT OF DIABETES MELLITUS

CURRENT MANAGEMENT OF DIABETES MELLITUS

by melody

DR. EBARE C KELVINS. SENIOR MEDICAL OFFICER. NHIS/...

Endocrinology: Type 2 Diabetes

Endocrinology: Type 2 Diabetes

by JollyJoker

Mellitus. Michael Canos, MD, MPH, MSc, FACE, FACP....

ltfYwx001FYY86Y475P89YY7

ltfYwx001FYY86Y475P89YY7

by piper

yREVIEWOpenAccessEffectoffenugreekTrigonellafoenum...

DHST2DMBestPracticesPage

DHST2DMBestPracticesPage

by anya

Type 2 Diabetes Mellitus in Adults diabetesmellit...

A Look Back on Diabetes in 2015 to Look Forward in 2016

A Look Back on Diabetes in 2015 to Look Forward in 2016

by conchita-marotz

A Look Back on Diabetes in 2015 to Look Forward i...

New Horizons in Adjunctive Type 1 Diabetes Management With

New Horizons in Adjunctive Type 1 Diabetes Management With

by luanne-stotts

SGLT Inhibitors. Program Overview. Glycemic Contr...

Detecting Diabetes Risk from Social Media Activity

Detecting Diabetes Risk from Social Media Activity

by tawny-fly

Dane Bell, . Egoitz. . Laparra. , Aditya . Kousi...

CV Risk Management in T2DM: What Did We Learn From EASD 2016?

CV Risk Management in T2DM: What Did We Learn From EASD 2016?

by marina-yarberry

Program Overview. EMPA-REG OUTCOME: Trial Design....

CV Risk Management in Diabetes: A Mandate for GLP-1 Receptor Agonists?

CV Risk Management in Diabetes: A Mandate for GLP-1 Receptor Agonists?

by pamella-moone

Introduction/Overview. Lowering HbA1c Reduces the...